Study Summary
This trial tests a drug's effectiveness in treating severe pneumonia in hospitalized patients who need critical care.
- Bacterial Pneumonia
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 4 Secondary · Reporting Duration: 28 days
Trial Safety
Phase-Based Safety
Trial Design
2 Treatment Groups
CAL02 with Standard of Care
1 of 2
Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
276 Total Participants · 2 Treatment Groups
Primary Treatment: CAL02 with Standard of Care · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What dangers should be taken into consideration when administering CAL02 in combination with Standard of Care to individuals?
"Our internal assessment of CAL02 in combination with Standard Of Care gave it a score of 2, as there is evidence indicating its safety but none to show its efficacy." - Anonymous Online Contributor
What is the scope of recruitment for this clinical trial?
"Affirmative. The clinicaltrials.gov page displays that this study is actively searching for participants; it was first posted on May 1st 2023 and updated lastly on May 15th 2023, with the need of 276 people from a single medical site." - Anonymous Online Contributor
Is enrollment open for this medical experiment?
"Affirmative. According to the information provided by clinicaltrials.gov, this medical research project is currently recruiting participants that were initially posted on May 1st 2023 and was subsequently updated on May 15th 2023. A total of 276 individuals are being sought from a single location." - Anonymous Online Contributor
What are the principal aims of this research endeavor?
"As per the research sponsor, Eagle Pharmaceuticals Inc., this clinical investigation has a primary outcome measure of efficacy-clinical recovery over 28 days. Secondary objectives include evaluating Sequential Organ Failure Assessment (SOFA) scores, the duration of critical care management and overall hospital stay in comparison to placebo administration. The SOFA score ranges from 0 - 24 with higher values indicating worse outcomes while hospital stays are measured by counting days until discharge occurs." - Anonymous Online Contributor